Accelerated liver recovery after acute CCl 4 poisoning in rats treated with sodium phthalhydrazide

Pharmacotherapy of hepatobiliary disorders is an important issue due to the high prevalence of liver failure, toxic and viral hepatitis and cirrhosis. The number of stimuli that can potentially induce or accelerate liver recovery is limited; in our study we selected sodium phthalhydrazide, which has...

Full description

Saved in:
Bibliographic Details
Published inInternational immunopharmacology Vol. 80; p. 106124
Main Authors Danilova, Irina G, Shafigullina, Zlata A, Gette, Irina F, Sencov, Valentin G, Medvedeva, Svetlana Yu, Abidov, Musa T
Format Journal Article
LanguageEnglish
Published Netherlands 01.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pharmacotherapy of hepatobiliary disorders is an important issue due to the high prevalence of liver failure, toxic and viral hepatitis and cirrhosis. The number of stimuli that can potentially induce or accelerate liver recovery is limited; in our study we selected sodium phthalhydrazide, which has been found to promote liver regeneration after partial hepatectomy. We examined the effects of phthalhydrazide on liver morphometric, histological and biochemical parameters in rats intoxicated with CCl . Accelerated liver recovery after CCl intoxication in phthalhydrazide-treated animals was evidenced by increased number of liver sinusoidal cells, reduced focal necrosis of hepatocytes and reduced perifocal leukocyte infiltration. Decreased plasma levels of pro-inflammatory cytokines TNF-α and IL-18 and decreased concentrations of IL-6 and IFN-γ in liver homogenates were associated with reduced severity of cholestasis and normalized hepatic protein synthesis in CCl -intoxicated rats exposed to phthalhydrazide. Anti-inflammatory and immunomodulating properties of phthahlhydrazide can be an important factor contributing to accelerated liver recovery at early stages of acute CCl -toxic liver impairment.
ISSN:1878-1705